(Press-News.org) PHILADELPHIA— For some patients with gastrointestinal (GI) cancers like colorectal and pancreatic cancer, chemotherapy can cause severe, sometimes life-threatening side effects in those who carry certain genetic variants that can impact how their bodies process the drugs used to treat their disease. Testing for variants in two genes before starting chemotherapy can significantly improve patient safety by providing physicians with information to help tailor doses, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Those who were found to have one of the genes had half as many side effects in half, as compared to patients with the genes that were given standard doses without testing, according to results published today in JCO Precision Oncology.
“For too long, the U.S. lagged behind Europe in adopting genetic testing for chemotherapy dosing, but our study shows it’s not only feasible but also critical for patient safety,” said the study’s lead author, Sony Tuteja, PharmD, MS, Director of Pharmacogenomics in the Penn Medicine Center for Genomic Medine, a research assistant professor of Translational Medicine and Human Genetics. “With up to 1,300 deaths in the U.S. each year due to side effects from one of the most common forms of chemotherapy drugs, we’ve worked to make testing fast and actionable, getting results in about a week to help doctors make safer treatment decisions.”
Nearly 290,000 Americans are diagnosed with gastrointestinal cancers each year – including colorectal cancer, the third most common cancer diagnosis in the nation. Current chemotherapy protocols use standard dosing standards that don’t account for genetic differences in how patients process these drugs.
Genetic Variants Guide Safer Chemotherapy
The study focused on variants in two genes: DPYD and UGT1A1. The DPYD gene produces an enzyme that helps the liver break down drugs like fluoropyrimidines, which are commonly used in gastrointestinal cancer treatment. About 5 to 8% of people carry DPYD variants that hinder the body’s ability to process fluoropyrimidine chemotherapy drugs, causing them to build up to harmful levels, which can lead to serious side effects like reduced blood cell production, mouth sores, or hand-foot syndrome. Similarly, the UGT1A1 gene affects how the body processes irinotecan, another key chemotherapy drug often used to treat GI cancers. Variants in UGT1A1 can lead to the body processing the drug too slowly, increasing the risk of severe diarrhea or low white blood cell counts. By identifying these variants, doctors can lower chemotherapy doses to prevent harmful side effects without compromising treatment effectiveness.
The study enrolled 517 GI cancer patients at three cancer care sites in the University of Pennsylvania Health System who were scheduled to begin chemotherapy treatment with fluoropyrimidine or irinotecan. A group of 288 received blood tests to check for DPYD and UGT1A1 variants. Among 16 patients who were found to have genetic variants and received tailored dose reductions based on test results, 38% experienced severe treatment-related adverse events. In comparison, 65% of 17 patients with the genetic variants from a biobank group who received standard doses without prior testing experienced the serious side effects. The tested group also saw a significantly lower need to change treatment dosage and frequency (38% vs. 76%) and fewer treatment discontinuations (31% vs. 47%), highlighting the potential of precision medicine to enhance patient safety and outcomes.
The research was funded in part by grants from the Penn Center for Precision Medicine and the National Institute of Health’s National Center for Advancing Translational Sciences (TL1TR001880).
The University of Pennsylvania Health System cares for patients in facilities and their homes stretching from the Susquehanna River in Pennsylvania to the New Jersey shore. UPHS facilities include the Hospital of the University of Pennsylvania, Penn Presbyterian Medical Center, Chester County Hospital, Doylestown Health, Lancaster General Health, Princeton Health, and Pennsylvania Hospital—the nation’s first hospital, chartered in 1751. Additional facilities and enterprises include Penn Medicine at Home, GSPP Rehabilitation, Lancaster Behavioral Health Hospital, and Princeton House Behavioral Health, among others.
Penn Medicine is an $11.9 billion enterprise powered by nearly 49,000 talented faculty and staff.
END
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients
Penn Medicine study shows tailored doses cut severe side effects
2025-08-07
ELSE PRESS RELEASES FROM THIS DATE:
UVic research predicts worldwide glacier erosion
2025-08-07
Glaciers carved the deep valleys of Banff, eroded Ontario to deposit the fertile soils of the Prairies and continue to change the Earth’s surface. But how fast do glaciers sculpt the landscape?
Published today in Nature Geoscience, University of Victoria (UVic) geographer Sophie Norris and her international team provide the most comprehensive view of how fast glaciers erode, and how they change the landscape. Most importantly, their research also provides an estimate of the rate of future erosion for more than 180,000 glaciers worldwide.
Using ...
A new boost for CryoZoo, Barcelona’s animal cell biobank
2025-08-07
The Barcelona CryoZoo is a one-of-a-kind project aiming to safeguard and study biological material from a wide range of animal species – especially those at risk of extinction – in order to preserve and better understand the planet’s biodiversity.
Born out of an initiative by the Barcelona Zoo Foundation, a space managed by BSM through the Barcelona Zoo Foundation, and that is developed jointly with University Pompeu Fabra (UPF), EMBL Barcelona, and the Natural Science Museum of Barcelona, CryoZoo has now been awarded a competitive grant from the wildlife conservation organisation Revive & Restore. This support ...
Asthma drug Zileuton blocks food allergy reactions in mice
2025-08-07
Scientists blocked a newly discovered anaphylaxis pathway in mice using Zileuton
Mice went from 95% susceptible to anaphylaxis to 95% protected
‘A totally different, out-of-the-box approach to treat food allergy’
Clinical trial recently launched to test the same approach in humans
CHICAGO --- A drug already FDA-approved for asthma was found to nearly eliminate life-threatening allergic reactions to food allergens in mice — a breakthrough that could lead to new protection for millions of people living with food allergies, reports a new Northwestern Medicine ...
Molecules in the spotlight: Snapshots reveal the eternal dance of particles
2025-08-07
FRANKFURT. Most of us find it difficult to grasp the quantum world: According to Heisenberg’s uncertainty principle, it’s like observing a dance without being able to see simultaneously exactly where someone is dancing and how fast they’re moving – you always must choose to focus on one. And yet, this quantum dance is far from chaotic; the dancers follow a strict choreography. In molecules, this strange behavior has another consequence: Even if a molecule should be completely frozen at absolute zero, it never truly comes to rest. The atoms it is made of perform a constant, never-ending quiet dance driven by so-called ...
What drives anaphylactic response in food allergies
2025-08-07
New research in mice reveals that food-induced anaphylaxis is driven by distinct immune pathways involving inflammatory lipids called leukotrienes. The findings, published across two separate studies, identify genetic and cellular factors that influence susceptibility to severe allergic reactions and point to the potential of the drug Zileuton to block this life-threatening response. Food allergies arise when the immune system mounts an exaggerated response to certain proteins found in foods. This reaction is typically driven by Immunoglobulin E (IgE) antibodies, which recognize dietary allergens and activates mast cells throughout the body. In severe ...
A thoughtful approach to governing emerging quantum technologies
2025-08-07
In a Policy Forum, Mateo Aboy and colleagues argue that, instead of turning immediately to rigid regulation to govern emerging quantum technologies, the community should apply a standards-based governance approach tailored to the early, technically focused stage of development. Quantum technologies are poised to revolutionize everything from computing to medicine, offering performance leaps that far surpass the limits of current systems. Yet, this promise comes with complex governance challenges, as these powerful tools ...
What makes the teeth of chitons iron hard?
2025-08-07
A group of marine mollusks called chitons produce extraordinarily tough teeth, which they use to scrape algae off rocks for food. Now, researchers report the protein RTMP1 (radular teeth matrix protein 1) appears to guide the precise formation of the iron-based mineral magnetite in the ultra-hard teeth of chitons. The findings mark the first known instance of an iron oxide-forming protein in a eukaryote, offering new insights into biomineralization and potential inspiration for novel materials design. Throughout the animal kingdom, many organisms ...
New antibody targeting approach, tested in mice, improves distribution and safety of Alzheimer’s immunotherapies
2025-08-07
A newly engineered antibody transport vehicle targeting the transferrin receptor enables enhanced delivery of anti-amyloid antibodies to the brains of mouse models of Alzheimer’s disease, researchers report. According to the study, the approach preserves key immune functions, such as microglial clearance of plaques, while offering a safer and more effective delivery strategy for anti–amyloid immunotherapies. Alzheimer’s disease (AD) is marked by the buildup of amyloid-β (Aβ) protein plaques in the brain. ...
UC Irvine scientist takes a lesson from ultrahard, wear-resistant mollusk teeth
2025-08-07
Irvine, Calif. — Researchers at the University of California, Irvine and Japan’s Okayama and Toho universities conducted a first-of-its-kind study to understand how chitons, mollusks that feed on algae growing on intertidal rocks, develop such hard, wear-resistant and magnetic teeth, and what they learned is inspiring new ways to produce advanced materials for a variety of applications. The results were published today in Science.
In its study, the team unveiled the process by which chiton-specific, iron-binding ...
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials
2025-08-07
The ability to detect single photons (the smallest energy packets constituting electromagnetic radiation) in the infrared range has become a pressing need across numerous fields, from medical imaging and astrophysics to emerging quantum technologies. In observational astronomy, for example, the light from distant celestial objects can be extremely faint and require exceptional sensitivity in the mid-infrared. Similarly, in free-space quantum communication—where single photons need to travel across vast distances—operating in ...
LAST 30 PRESS RELEASES:
Illinois Tech hosts EV Readiness Community Awards, showcasing nation-leading energy innovation
Rice bioscientist wins NSF CAREER Award to investigate bacterial toxins, expand inclusion in STEM
Study links exercise with decreased mortality and cardiovascular events in people recently diagnosed with type 2 diabetes but no previous cardiovascular disease
Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patients
UVic research predicts worldwide glacier erosion
A new boost for CryoZoo, Barcelona’s animal cell biobank
Asthma drug Zileuton blocks food allergy reactions in mice
Molecules in the spotlight: Snapshots reveal the eternal dance of particles
What drives anaphylactic response in food allergies
A thoughtful approach to governing emerging quantum technologies
What makes the teeth of chitons iron hard?
New antibody targeting approach, tested in mice, improves distribution and safety of Alzheimer’s immunotherapies
UC Irvine scientist takes a lesson from ultrahard, wear-resistant mollusk teeth
ICFO researchers overcome long-standing bottleneck in single photon detection with twisted 2D materials
New scaffold technology helps combat traumatic brain injury by restoring copper balance
Bone metastases cultivate immature immune cells to resist immunotherapy
Liming can help enhance carbon capture in agricultural fields
National study urges expanded vaccine screening in emergency departments
Simple color-changing sensor quickly identifies poisonous gases
Exosomes found to play a double role in tumor growth and immune response
Announcing Gordian Biotechnology as Tier 5 Sponsor of ARDD 2025
Disconnection between brain regions explains why some people don’t enjoy music
An interstellar mission to a black hole? Astrophysicist thinks it’s possible.
Earth’s natural CO2 vacuum cleaners
It's not all about size
Cost-effectiveness of 2023-2024 COVID-19 vaccination in US adults
Demographics, lifestyle, comorbidities, prediabetes, and mortality
Climate change: Perito Moreno Glacier retreat has recently accelerated substantially
Population history of the Southern Caucasus
Biomarkers reveal risk of cardiovascular disease in type 2 diabetes
[Press-News.org] Genetic testing reduces risks from chemotherapy for gastrointestinal cancer patientsPenn Medicine study shows tailored doses cut severe side effects